Medical specialists from Canada tagged as investigators in clinical trials studying Carcinoma
Total 172 results
-
Adrian Sacher, MDSeen in:
- Ontario, Toronto, Princess Margaret Cancer Centre
Trials:- NCT04563338 (Principal Investigator)
-
Al CovensSeen in:
- Ontario, Toronto, Sunnybrook Research Institute
Trials:- NCT05611931 (Principal Investigator)
Conditions: -
Alexander V. LouieSeen in:
- Ontario, Toronto, Odette Cancer Centre- Sunnybrook Health Sciences Centre
Trials:- NCT04155034 (Principal Investigator)
-
Alexander Y. SunSeen in:
- Ontario, Toronto, University Health Network-Princess Margaret Hospital
Trials:- NCT04155034 (Principal Investigator)
-
Ali A. El-GayedSeen in:
- Saskatchewan, Saskatoon, Saskatoon Cancer Centre
Trials:- NCT01810913 (Principal Investigator)
- NCT04852887 (Principal Investigator)
- NCT05050084 (Principal Investigator)
Conditions:- Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7;
- Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7;
- Stage IV Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7;
- Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7;
- Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma;
- Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7;
- Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7;
- Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7;
- Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7;
- Stage I Breast Cancer;
- Prostate Adenocarcinoma
-
Allan L. CovensSeen in:
- Ontario, Toronto, Odette Cancer Centre- Sunnybrook Health Sciences Centre
Trials:- NCT03067181 (Principal Investigator)
Conditions:- Malignant Germ Cell Tumor;
- Germ Cell Tumor;
- Childhood Extracranial Germ Cell Tumor;
- Extragonadal Embryonal Carcinoma;
- Malignant Ovarian Teratoma;
- Stage I Ovarian Choriocarcinoma;
- Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage I Ovarian Teratoma AJCC v6 and v7;
- Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage I Testicular Choriocarcinoma AJCC v6 and v7;
- Stage I Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage I Testicular Seminoma AJCC v6 and v7;
- Stage I Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage II Ovarian Choriocarcinoma;
- Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage II Testicular Choriocarcinoma AJCC v6 and v7;
- Stage II Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage II Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage III Ovarian Choriocarcinoma;
- Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage III Testicular Choriocarcinoma AJCC v6 and v7;
- Stage III Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage III Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage IV Ovarian Choriocarcinoma;
- Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Testicular Mixed Choriocarcinoma and Embryonal Carcinoma;
- Testicular Mixed Choriocarcinoma and Teratoma;
- Testicular Mixed Choriocarcinoma and Yolk Sac Tumor
-
Amit OzaSeen in:
- Ontario, Toronto, Princess Margaret Cancer Centre
- Ontario, Toronto, Princess Margaret Cancer Centre - University Health Network
- Ontario, Toronto, Princess Margaret Hospital
- Ontario, Toronto, University Health Network - Princess Margaret Hospital
- Ontario, Toronto, University Health Network, Princess Margaret Hospital
- Ontario, Toronto, University health Network (UHN)-University of Toronto
- Toronto, Princess Margaret Cancer Center
- Toronto, Princess Margaret Cancer Centre
Trials:- NCT05483933 (Principal Investigator)
- NCT04260802 (Principal Investigator)
- NCT05041257 (Principal Investigator)
- NCT02632448 (Principal Investigator)
- NCT04625270 (Principal Investigator)
- NCT05445778 (Principal Investigator)
- NCT05229900 (Principal Investigator)
- NCT04159155 (Principal Investigator)
- NCT02334761 (Principal Investigator)
- NCT05870748 (Principal Investigator)
- NCT06003231 (Principal Investigator)
Conditions:- Ovarian Cancer;
- Fallopian Tube Cancer;
- Epithelial Ovarian Cancer;
- Platinum-resistant Ovarian Cancer;
- Primary Peritoneal Carcinoma;
- Platinum-Resistant Fallopian Tube Carcinoma;
- Platinum-Resistant Primary Peritoneal Carcinoma;
- Sarcoma;
- Neoplasms;
- Renal Cell Carcinoma;
- Cervical Cancer;
- Cancer;
- Hepatocellular Carcinoma;
- Gastric Cancer;
- Non Small Cell Lung Cancer;
- Metastatic Cancer;
- Squamous Cell Carcinoma of Head and Neck;
- Bladder Cancer;
- Triple Negative Breast Cancer;
- Urothelial Carcinoma;
- Merkel Cell Carcinoma;
- Squamous Cell Carcinoma;
- Locally Advanced Malignant Neoplasm;
- Locally Advanced Solid Tumor;
- Urothelial Neoplasm;
- Peritoneal Cancer;
- Soft Tissue Sarcoma;
- Breast Cancer;
- Colorectal Cancer;
- Pancreatic Cancer;
- Rectal Cancer;
- Endometrial Cancer;
- Colon Cancer;
- Solid Tumors;
- Pancreas Cancer;
- Low Grade Ovarian Serous Adenocarcinoma;
- Uterine Cervical Neoplasms;
- Stomach Neoplasms;
- Testicular Neoplasms;
- Carcinoma, Non-Small-Cell Lung;
- Ovarian Neoplasms;
- Endometrial Neoplasms;
- Gastroesophageal Junction Carcinoma;
- Endometrial Carcinoma;
- P53 Mutation;
- Serous Carcinoma;
- Pathology;
- Primary Peritoneal Cancer;
- Carcinoma, Squamous Cell of Head and Neck
-
An-Wen ChanSeen in:
- Ontario, Toronto, Toronto General Hospital
- Ontario, Toronto, Women's College Hospital
Trials:- NCT05955924 (Principal Investigator)
-
Anand SwaminathSeen in:
- Ontario, Hamilton, Juravinski Cancer Centre
- Ontario, Hamilton, Juravinski Cancer Centre at Hamilton Health Sciences
Trials:- NCT04155034 (Principal Investigator)
- NCT04435938 (Sub-Investigator)
-
André LacroixSeen in:
- Montreal, Endocrinologie - Centre hospitalier de l'Université de Montréal (CHUM)
Trials:- NCT00777244 (Principal Investigator)
Conditions: -
Anna SpreaficoSeen in:
- Ontario, Toronto, GSK Investigational Site
- Ontario, Toronto, Princess Margaret Cancer Centre
- Ontario, Toronto, University Health Network-Princess Margaret Hospital
- Other, Toronto, University Health Network, Princess Margaret Hospital
- Toronto, University Health Network, Princess Margaret Hospital
Trials:- NCT03816345 (Principal Investigator)
- NCT05208762 (Principal Investigator)
- NCT06256588 (Principal Investigator)
- NCT04050436 (Principal Investigator)
Conditions:- Hematopoietic and Lymphoid Cell Neoplasm;
- Malignant Solid Neoplasm;
- Multiple Sclerosis;
- Rheumatoid Arthritis;
- Systemic Lupus Erythematosus;
- Psoriasis;
- Systemic Scleroderma;
- Crohn Disease;
- Ulcerative Colitis;
- Dermatomyositis;
- Psoriatic Arthritis;
- Inflammatory Bowel Disease;
- Autoimmune Disease;
- Sjogren Syndrome;
- Melanoma;
- Carcinoma, Non-Small-Cell Lung;
- Gastric Cancer;
- Ovarian Neoplasms;
- Squamous Cell Carcinoma of the Head and Neck;
- Triple Negative Breast Neoplasms;
- Esophageal Squamous Cell Carcinoma;
- Neoplasms, Head and Neck;
- Cutaneous Squamous Cell Carcinoma;
- Advanced Cutaneous Squamous Cell Carcinoma;
- Metastatic Cutaneous Squamous Cell Carcinoma
-
Anthony Nichols, MDSeen in:
- Ontario, London, Lawson Health Research Institute
Trials:- NCT04624477 (Principal Investigator)
-
Antonio Finelli, MD MSc FRCSCSeen in:
- Ontario, Toronto, University Health Network, Princess Margaret Hospital
Trials:- NCT04005183 (Principal Investigator)
Conditions: -
April Rose, MD, PhDSeen in:
- Quebec, Montreal, Jewish General Hospital
Trials:- NCT04879329 (Principal Investigator)
Conditions: -
Arif AwanSeen in:
- Ontario, Ottawa, Ottawa Hospital Cancer Centre
- Ontario, Ottawa, University of Ottawa / Ottawa General Hospital
Trials:- NCT05571839 (Principal Investigator)
- NCT04609566 (Principal Investigator)
- NCT05194072 (Principal Investigator)
- NCT04665921 (Principal Investigator)
- NCT05229900 (Principal Investigator)
Conditions:- Colorectal Neoplasms;
- Pancreatic Neoplasms;
- Mesothelioma;
- Non-small Cell Lung Cancer;
- Cutaneous Melanoma;
- Melanoma;
- Squamous Cell Carcinoma of the Head and Neck;
- Carcinoma, Non-Small-Cell Lung;
- Adenoid Cystic Carcinoma;
- Ovarian Neoplasms;
- Fallopian Tube Neoplasms;
- Peritoneal Neoplasms;
- Endometrial Neoplasms;
- Cholangiocarcinoma;
- Triple Negative Breast Neoplasms;
- Gallbladder Carcinoma;
- HER2 Negative Breast Neoplasms;
- Hormone Receptor Positive Breast Neoplasms;
- Uterine Cervical Neoplasms;
- Stomach Neoplasms;
- Esophageal Neoplasms;
- Pseudomyxoma Peritonei;
- Carcinoma, Non-Small Cell Lung;
- Gastroesophageal Junction Carcinoma;
- Exocrine Pancreatic Adenocarcinoma;
- Appendiceal Adenocarcinoma;
- Testicular Neoplasms
-
Ashley ChopekSeen in:
- Manitoba, Winnipeg, CancerCare Manitoba
Trials:- NCT04759586 (Principal Investigator)
- NCT05457556 (Principal Investigator)
- NCT03794349 (Principal Investigator)
- NCT03067181 (Principal Investigator)
- NCT05099003 (Principal Investigator)
- NCT03914625 (Principal Investigator)
- NCT03007147 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT05304585 (Principal Investigator)
- NCT04684368 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT03817398 (Principal Investigator)
- NCT04726241 (Principal Investigator)
- NCT05675410 (Principal Investigator)
- NCT04994132 (Principal Investigator)
- NCT03959085 (Principal Investigator)
- NCT03223753 (Principal Investigator)
Conditions:- Primary Mediastinal Large B-Cell Lymphoma;
- Acute Myeloid Leukemia;
- Acute Lymphoblastic Leukemia;
- Myelodysplastic Syndrome;
- Mixed Phenotype Acute Leukemia;
- Recurrent Neuroblastoma;
- Refractory Neuroblastoma;
- High Risk Neuroblastoma;
- Malignant Germ Cell Tumor;
- Germ Cell Tumor;
- Childhood Extracranial Germ Cell Tumor;
- Extragonadal Embryonal Carcinoma;
- Malignant Ovarian Teratoma;
- Stage I Ovarian Choriocarcinoma;
- Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage I Ovarian Teratoma AJCC v6 and v7;
- Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage I Testicular Choriocarcinoma AJCC v6 and v7;
- Stage I Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage I Testicular Seminoma AJCC v6 and v7;
- Stage I Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage II Ovarian Choriocarcinoma;
- Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage II Testicular Choriocarcinoma AJCC v6 and v7;
- Stage II Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage II Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage III Ovarian Choriocarcinoma;
- Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage III Testicular Choriocarcinoma AJCC v6 and v7;
- Stage III Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage III Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage IV Ovarian Choriocarcinoma;
- Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Testicular Mixed Choriocarcinoma and Embryonal Carcinoma;
- Testicular Mixed Choriocarcinoma and Teratoma;
- Testicular Mixed Choriocarcinoma and Yolk Sac Tumor;
- Glioblastoma;
- Malignant Glioma;
- Anaplastic Astrocytoma;
- Anaplastic Astrocytoma, Not Otherwise Specified;
- Diffuse Intrinsic Pontine Glioma;
- Diffuse Midline Glioma, H3 K27M-Mutant;
- Glioblastoma, Not Otherwise Specified;
- Down Syndrome;
- B Acute Lymphoblastic Leukemia;
- B Lymphoblastic Lymphoma;
- T Acute Lymphoblastic Leukemia;
- Malignant Solid Neoplasm;
- Neuroendocrine Neoplasm;
- Myeloproliferative Neoplasm;
- Desmoid Fibromatosis;
- Lymphoproliferative Disorder;
- Carcinoma In Situ;
- Central Nervous System Neoplasm;
- Ganglioneuroma;
- Congenital Mesoblastic Nephroma;
- Childhood Immature Teratoma;
- Childhood Langerhans Cell Histiocytosis;
- Childhood Mature Teratoma;
- Stromal Neoplasm;
- Melanocytic Neoplasm;
- Embryonal Rhabdomyosarcoma;
- Fusion-Negative Alveolar Rhabdomyosarcoma;
- Spindle Cell/Sclerosing Rhabdomyosarcoma;
- Choriocarcinoma;
- Embryonal Carcinoma;
- Mixed Germ Cell Tumor;
- Central Nervous System Nongerminomatous Germ Cell Tumor;
- Immature Teratoma;
- Malignant Teratoma;
- Pineal Region Germ Cell Tumor;
- Pineal Region Immature Teratoma;
- Pineal Region Yolk Sac Tumor;
- Suprasellar Germ Cell Tumor;
- Stage II Kidney Wilms Tumor;
- Stage III Kidney Wilms Tumor;
- Stage IV Kidney Wilms Tumor;
- Recurrent Kidney Wilms Tumor;
- Anaplastic Kidney Wilms Tumor;
- Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive;
- Juvenile Myelomonocytic Leukemia;
- Myeloid Leukemia Associated With Down Syndrome;
- Acute Myeloid Leukemia Post Cytotoxic Therapy;
- Myelodysplastic Syndrome Post Cytotoxic Therapy;
- Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8;
- Alveolar Rhabdomyosarcoma;
- Botryoid-Type Embryonal Rhabdomyosarcoma;
- Spindle Cell Rhabdomyosarcoma;
- Metastatic Embryonal Rhabdomyosarcoma;
- Metastatic Rhabdomyosarcoma;
- Solid Alveolar Rhabdomyosarcoma;
- Central Nervous System Leukemia;
- Testicular Leukemia;
- Hematopoietic and Lymphatic System Neoplasm
-
Ayesha BashirSeen in:
- Saskatchewan, Regina, Allan Blair Cancer Centre
Trials:- NCT05050162 (Principal Investigator)
-
Bashir M. BashirSeen in:
- Manitoba, Winnipeg, CancerCare Manitoba
Trials:- NCT03488693 (Principal Investigator)
- NCT04155034 (Principal Investigator)
-
Bassam S. AbdulkarimSeen in:
- Quebec, Montreal, The Research Institute of the McGill University Health Centre (MUHC)
Trials:- NCT04155034 (Principal Investigator)
- NCT03180268 (Principal Investigator)
-
Bernhard EiglSeen in:
- British Columbia, Vancouver, British Columbia Cancer Agency - Vancouver Centre
Trials:- NCT04879329 (Principal Investigator)
Conditions: -
Brock Debenham, MDSeen in:
- Alberta, Edmonton, Cross Cancer Institute
Trials:- NCT03546582 (Principal Investigator)
Conditions: -
Brock J. DebenhamSeen in:
- Alberta, Edmonton, Cross Cancer Institute
Trials:- NCT01810913 (Principal Investigator)
Conditions:- Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7;
- Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7;
- Stage IV Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7;
- Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7;
- Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma;
- Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7;
- Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7;
- Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7;
- Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7
-
Bruno MichonSeen in:
- Quebec, CHU de Quebec-Centre Hospitalier de l'Universite Laval (CHUL)
- Quebec, Centre Hospitalier Universitaire de Quebec
Trials:- NCT04759586 (Principal Investigator)
- NCT04576117 (Principal Investigator)
- NCT04166409 (Principal Investigator)
- NCT01790152 (Principal Investigator)
- NCT03794349 (Principal Investigator)
- NCT03533582 (Principal Investigator)
- NCT03067181 (Principal Investigator)
- NCT05099003 (Principal Investigator)
- NCT03914625 (Principal Investigator)
- NCT03007147 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT05304585 (Principal Investigator)
- NCT04684368 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT03817398 (Principal Investigator)
- NCT04726241 (Principal Investigator)
- NCT04293562 (Principal Investigator)
- NCT05675410 (Principal Investigator)
- NCT02176967 (Principal Investigator)
- NCT00904241 (Principal Investigator)
- NCT04994132 (Principal Investigator)
- NCT03959085 (Principal Investigator)
Conditions:- Primary Mediastinal Large B-Cell Lymphoma;
- Recurrent WHO Grade 2 Glioma;
- Recurrent Low Grade Astrocytoma;
- Refractory Low Grade Astrocytoma;
- Refractory Low Grade Glioma;
- Refractory WHO Grade 1 Glioma;
- Low Grade Glioma;
- Low Grade Astrocytoma;
- Metastatic Low Grade Astrocytoma;
- Metastatic Low Grade Glioma;
- Osteosarcoma;
- Lymphoblastic Lymphoma;
- Recurrent Lymphoma;
- Recurrent Malignant Neoplasm;
- Hodgkin Lymphoma in Remission;
- Leukemia in Remission;
- Recurrent Leukemia;
- Recurrent Neuroblastoma;
- Refractory Neuroblastoma;
- High Risk Neuroblastoma;
- Hepatoblastoma;
- Fibrolamellar Carcinoma;
- Childhood Hepatocellular Carcinoma;
- Childhood Malignant Liver Neoplasm;
- Hepatocellular Malignant Neoplasm, Not Otherwise Specified;
- Malignant Germ Cell Tumor;
- Germ Cell Tumor;
- Childhood Extracranial Germ Cell Tumor;
- Extragonadal Embryonal Carcinoma;
- Malignant Ovarian Teratoma;
- Stage I Ovarian Choriocarcinoma;
- Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage I Ovarian Teratoma AJCC v6 and v7;
- Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage I Testicular Choriocarcinoma AJCC v6 and v7;
- Stage I Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage I Testicular Seminoma AJCC v6 and v7;
- Stage I Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage II Ovarian Choriocarcinoma;
- Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage II Testicular Choriocarcinoma AJCC v6 and v7;
- Stage II Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage II Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage III Ovarian Choriocarcinoma;
- Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage III Testicular Choriocarcinoma AJCC v6 and v7;
- Stage III Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage III Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage IV Ovarian Choriocarcinoma;
- Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Testicular Mixed Choriocarcinoma and Embryonal Carcinoma;
- Testicular Mixed Choriocarcinoma and Teratoma;
- Testicular Mixed Choriocarcinoma and Yolk Sac Tumor;
- Glioblastoma;
- Malignant Glioma;
- Anaplastic Astrocytoma;
- Anaplastic Astrocytoma, Not Otherwise Specified;
- Diffuse Intrinsic Pontine Glioma;
- Diffuse Midline Glioma, H3 K27M-Mutant;
- Glioblastoma, Not Otherwise Specified;
- Down Syndrome;
- B Acute Lymphoblastic Leukemia;
- B Lymphoblastic Lymphoma;
- Acute Lymphoblastic Leukemia;
- T Acute Lymphoblastic Leukemia;
- Mixed Phenotype Acute Leukemia;
- Malignant Solid Neoplasm;
- Neuroendocrine Neoplasm;
- Myeloproliferative Neoplasm;
- Desmoid Fibromatosis;
- Lymphoproliferative Disorder;
- Carcinoma In Situ;
- Central Nervous System Neoplasm;
- Ganglioneuroma;
- Congenital Mesoblastic Nephroma;
- Childhood Immature Teratoma;
- Childhood Langerhans Cell Histiocytosis;
- Childhood Mature Teratoma;
- Stromal Neoplasm;
- Melanocytic Neoplasm;
- Embryonal Rhabdomyosarcoma;
- Fusion-Negative Alveolar Rhabdomyosarcoma;
- Spindle Cell/Sclerosing Rhabdomyosarcoma;
- Choriocarcinoma;
- Embryonal Carcinoma;
- Mixed Germ Cell Tumor;
- Central Nervous System Nongerminomatous Germ Cell Tumor;
- Immature Teratoma;
- Malignant Teratoma;
- Pineal Region Germ Cell Tumor;
- Pineal Region Immature Teratoma;
- Pineal Region Yolk Sac Tumor;
- Suprasellar Germ Cell Tumor;
- Stage II Kidney Wilms Tumor;
- Stage III Kidney Wilms Tumor;
- Stage IV Kidney Wilms Tumor;
- Recurrent Kidney Wilms Tumor;
- Anaplastic Kidney Wilms Tumor;
- Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive;
- Acute Myeloid Leukemia;
- Juvenile Myelomonocytic Leukemia;
- Myelodysplastic Syndrome;
- Myeloid Leukemia Associated With Down Syndrome;
- Acute Myeloid Leukemia Post Cytotoxic Therapy;
- Myelodysplastic Syndrome Post Cytotoxic Therapy;
- Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8;
- Neuroblastoma;
- Localized Resectable Neuroblastoma;
- Localized Unresectable Neuroblastoma;
- Ganglioneuroblastoma;
- Regional Neuroblastoma;
- Stage 4S Neuroblastoma;
- Stage 4 Neuroblastoma;
- Alveolar Rhabdomyosarcoma;
- Botryoid-Type Embryonal Rhabdomyosarcoma;
- Spindle Cell Rhabdomyosarcoma;
- Metastatic Embryonal Rhabdomyosarcoma;
- Metastatic Rhabdomyosarcoma;
- Solid Alveolar Rhabdomyosarcoma;
- Central Nervous System Leukemia;
- Testicular Leukemia
-
Caroline LavoieSeen in:
- Quebec, Quebec City, CHU de Quebec-L'Hotel-Dieu de Quebec (HDQ)
Trials:- NCT04155034 (Principal Investigator)
-
Catherine SperlichSeen in:
- Greenfield Park, CISSS de la Monteregie-Centre - Hospital Charles Le Moyne
Trials:- NCT05327530 (Principal Investigator)
-
Christina M CanilSeen in:
- Ottawa, The Ottawa Hospital Cancer Centre
Trials:- NCT05327530 (Principal Investigator)
-
Christine Lambert, MDSeen in:
- Quebec, Montréal, McGill University Health Centre
Trials:- NCT04797299 (Principal Investigator)
Conditions:
Clinical Trials on Carcinoma
-
Eye & ENT Hospital of Fudan UniversityChanghai Hospital; Fudan University; RenJi Hospital; Xinhua Hospital, Shanghai... and other collaboratorsRecruitingGlottic Carcinoma | Supraglottic Carcinoma | Subglottic Carcinoma | Pyriform Sinus Carcinoma | Postcricoid Carcinoma | Posterior Pharyngeal Wall CarcinomaChina
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingEstrogen Receptor Positive | Ductal Breast Carcinoma In Situ | Grade 1 Invasive Breast Carcinoma | Grade 2 Invasive Breast Carcinoma | Grade 3 Invasive Breast Carcinoma | Invasive Ductal and Lobular Carcinoma In Situ | Mucinous Breast Carcinoma | Tubular Breast CarcinomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingMetastatic Bladder Urothelial Carcinoma | Metastatic Renal Pelvis Urothelial Carcinoma | Metastatic Ureter Urothelial Carcinoma | Metastatic Urethral Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Locally Advanced Bladder Urothelial Carcinoma | Locally Advanced Renal Pelvis Urothelial... and other conditionsUnited States
-
National Cancer Institute (NCI)Not yet recruitingBreast Carcinoma | Breast Ductal Carcinoma In Situ | Breast Lobular Carcinoma In Situ | Estrogen Receptor-Positive Breast CarcinomaUnited States
-
Roswell Park Cancer InstituteIovance Biotherapeutics, Inc.WithdrawnMetastatic Bladder Urothelial Carcinoma | Metastatic Renal Pelvis Urothelial Carcinoma | Metastatic Ureter Urothelial Carcinoma | Metastatic Urethral Urothelial Carcinoma | Unresectable Renal Pelvis Urothelial Carcinoma | Unresectable Ureter Urothelial CarcinomaUnited States
-
Mamta ParikhNational Cancer Institute (NCI); Karyopharm Therapeutics IncRecruitingMetastatic Urothelial Carcinoma | Locally Advanced Urothelial Carcinoma | Advanced Urothelial Carcinoma | Refractory Urothelial CarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingBreast Ductal Carcinoma In Situ | Invasive Breast Carcinoma | Multicentric Breast Carcinoma | Multifocal Breast Carcinoma | Synchronous Bilateral Breast CarcinomaUnited States, France, Spain, Canada, Saudi Arabia, Puerto Rico, Korea, Republic of, Ireland, Colombia, Mexico
-
Ohio State University Comprehensive Cancer CenterEmbr Labs, Inc.Active, not recruitingHot Flashes | Breast Carcinoma | Breast Ductal Carcinoma In Situ | Breast Lobular Carcinoma In SituUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell Carcinoma | Recurrent Lip and Oral Cavity Squamous Cell Carcinoma | Recurrent Laryngeal Verrucous Carcinoma | Recurrent Oral Cavity Verrucous Carcinoma | Tongue... and other conditionsUnited States
-
Institut BergoniéCompletedIntraductal Carcinoma and Lobular Carcinoma in SituFrance